Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 1585-1589, August 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmid, F. A.
Right arrow Articles by Tarnowski, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmid, F. A.
Right arrow Articles by Tarnowski, G. S.

Genetic Determination of Differential Inflammatory Reactivity and Subcutaneous Tumor Susceptibility of AKR/J and C57BL/6J Mice to 7,12-Dimethylbenz[a] anthracene1

F. A. Schmid, I. Elmer and G. S. Tarnowski

Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, New York 10021

Since previous work has shown that 7,12-dimethylbenz[a]-anthracene (DMBA) causes less inflammation in AKR/J than in C57BL/6J mice, the genetic nature of this differential inflammatory response was investigated. The criterion for high reactivity was the formation of ulcers after skin application of DMBA. F1 hybrids were slightly less high reacting than the C57BL/6J mice. Of the F2, 72% were high reacting. The back-cross of F1 hybrids to C57BL/6J produced only high reactors, but to AKR/J high- and low-reacting mice. Mating of low-reacting F1 backcross mice to C57BL/6J mice yielded 100%, and to AKR/J 0%, high reactors. Backcross of low-reacting F2 mice to C57BL/6J gave 100%, and to AKR/J 0%, high-reacting mice. Backcross of high-reacting F1 backcross and F2 mice to C57BL/6J yielded only high-reacting, and to AKR/J high- and low-reacting, mice. These findings suggest that the low inflammatory response of the AKR/J mice is controlled by a single incompletely recessive factor. Results with DBA/2J mice, their F1 hybrids, and backcrosses of these F1 hybrids to AKR/J, also indicated inheritance by a single autosomal genetic factor. The higher inflammatory reactivity of the C57BL/6J mice was accompanied by higher susceptibility to subcutaneous tumor induction by DMBA. Furthermore, results with mice differing only in inflammatory reactivity showed that inflammatory reactivity and susceptibility to s.c. tumor induction are inherited together and are probably directly related.

1 This study was supported by National Cancer Institute Grant CA 08748.

Received 12/ 6/68. Accepted 4/ 7/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.